Bilateral progressive orbital myositis as immune-related adverse event of pembrolizumab.

Suppr

超能文献

作者信息

Nakajima Isana, Nakaizumi Tomoko, Tsuji Hideki

机构信息

Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan.

出版信息

Can J Ophthalmol. 2024 Aug;59(4):e388. doi: 10.1016/j.jcjo.2024.02.007. Epub 2024 Mar 8.

DOI:10.1016/j.jcjo.2024.02.007

PMID:38462232

Abstract

摘要

相似文献

Bilateral progressive orbital myositis as immune-related adverse event of pembrolizumab.

Can J Ophthalmol. 2024 Aug;59(4):e388. doi: 10.1016/j.jcjo.2024.02.007. Epub 2024 Mar 8.

Checkpoint inhibitor myasthenia-like syndrome and myositis associated with extraocular muscle atrophy.

J Clin Neurosci. 2020 Jan;71:271-272. doi: 10.1016/j.jocn.2019.11.038. Epub 2019 Dec 27.

Orbital myositis and psoriatic arthritis.

Can J Ophthalmol. 2012 Dec;47(6):e42-3. doi: 10.1016/j.jcjo.2012.04.005. Epub 2012 Sep 25.

Orbital Myositis.

Clin Pediatr (Phila). 2017 Apr;56(4):385-388. doi: 10.1177/0009922816660692. Epub 2016 Jul 28.

Pembrolizumab-induced necrotic myositis in a patient with metastatic melanoma.

Ann Oncol. 2016 Jul;27(7):1352-3. doi: 10.1093/annonc/mdw126. Epub 2016 Mar 2.

Pembrolizumab-associated ocular myasthenia gravis.

Clin Exp Ophthalmol. 2019 Aug;47(6):796-798. doi: 10.1111/ceo.13499. Epub 2019 Apr 1.

Isolated medial rectus orbital myositis as a manifestation of idiopathic orbital inflammation.

Acta Neurol Belg. 2011 Mar;111(1):78-9.

Pembrolizumab induced bulbar myopathy and respiratory failure with necrotizing myositis of the diaphragm.

Ann Oncol. 2017 Mar 1;28(3):673-675. doi: 10.1093/annonc/mdw655.

Orbital myositis: diagnosis and management.

Curr Allergy Asthma Rep. 2009 Jul;9(4):316-23. doi: 10.1007/s11882-009-0045-y.

Pembrolizumab-associated inflammatory myopathy.

Rheumatology (Oxford). 2018 Feb 1;57(2):397-398. doi: 10.1093/rheumatology/kex346.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Bilateral progressive orbital myositis as immune-related adverse event of pembrolizumab.

Can J Ophthalmol. 2024 Aug;59(4):e388. doi: 10.1016/j.jcjo.2024.02.007. Epub 2024 Mar 8.

Checkpoint inhibitor myasthenia-like syndrome and myositis associated with extraocular muscle atrophy.

J Clin Neurosci. 2020 Jan;71:271-272. doi: 10.1016/j.jocn.2019.11.038. Epub 2019 Dec 27.

Orbital myositis and psoriatic arthritis.

Can J Ophthalmol. 2012 Dec;47(6):e42-3. doi: 10.1016/j.jcjo.2012.04.005. Epub 2012 Sep 25.

Orbital Myositis.

Clin Pediatr (Phila). 2017 Apr;56(4):385-388. doi: 10.1177/0009922816660692. Epub 2016 Jul 28.

Pembrolizumab-induced necrotic myositis in a patient with metastatic melanoma.

Ann Oncol. 2016 Jul;27(7):1352-3. doi: 10.1093/annonc/mdw126. Epub 2016 Mar 2.

Pembrolizumab-associated ocular myasthenia gravis.

Clin Exp Ophthalmol. 2019 Aug;47(6):796-798. doi: 10.1111/ceo.13499. Epub 2019 Apr 1.

Isolated medial rectus orbital myositis as a manifestation of idiopathic orbital inflammation.

Acta Neurol Belg. 2011 Mar;111(1):78-9.

Pembrolizumab induced bulbar myopathy and respiratory failure with necrotizing myositis of the diaphragm.

Ann Oncol. 2017 Mar 1;28(3):673-675. doi: 10.1093/annonc/mdw655.

Orbital myositis: diagnosis and management.

Curr Allergy Asthma Rep. 2009 Jul;9(4):316-23. doi: 10.1007/s11882-009-0045-y.

Pembrolizumab-associated inflammatory myopathy.

Rheumatology (Oxford). 2018 Feb 1;57(2):397-398. doi: 10.1093/rheumatology/kex346.